Isoniazid-gelatin conjugate microparticles containing rifampicin for the treatment of tuberculosis.
about
Advances in device and formulation technologies for pulmonary drug delivery.Cyto-genotoxicity Assessment of Potential Anti-tubercular Drug Candidate Molecule-trans-cyclohexane-1, 4-diamine Derivative-9u in Human Lung Epithelial Cells A549.Gelatin-based particulate systems in ocular drug delivery.Drug delivery from gelatin-based systems.Pulmonary drug delivery system: newer patents.
P2860
Isoniazid-gelatin conjugate microparticles containing rifampicin for the treatment of tuberculosis.
description
2013 nî lūn-bûn
@nan
2013 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Isoniazid-gelatin conjugate mi ...... the treatment of tuberculosis.
@ast
Isoniazid-gelatin conjugate mi ...... the treatment of tuberculosis.
@en
Isoniazid-gelatin conjugate mi ...... the treatment of tuberculosis.
@nl
type
label
Isoniazid-gelatin conjugate mi ...... the treatment of tuberculosis.
@ast
Isoniazid-gelatin conjugate mi ...... the treatment of tuberculosis.
@en
Isoniazid-gelatin conjugate mi ...... the treatment of tuberculosis.
@nl
prefLabel
Isoniazid-gelatin conjugate mi ...... the treatment of tuberculosis.
@ast
Isoniazid-gelatin conjugate mi ...... the treatment of tuberculosis.
@en
Isoniazid-gelatin conjugate mi ...... the treatment of tuberculosis.
@nl
P2093
P2860
P50
P356
P1476
Isoniazid-gelatin conjugate mi ...... the treatment of tuberculosis.
@en
P2093
Donatella Valenti
Roberta Cassano
Teresa Ferrarelli
P2860
P304
P356
10.1111/JPHP.12094
P577
2013-07-05T00:00:00Z